Capvizr
THE DEAL, AT A GLANCE

Skribe Medical

2/4 reviewed
01What it doesSkribe is developing a wearable patch to help doctors assess heart function during cancer treatment.Source-grounded · automated review · Explore ↗

Checked 2026-11-14 · Review due 2026-11-21

Read supporting source ↗
Skribe is a wearable cardio-oncology…
02Who is involvedBacked by SeaX Ventures, GoAhead Ventures, Marin Sonoma Impact VenturesFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedSkribe Medical raised $1.6M Pre-Seed, announced 2026-11-12From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersFaster heart assessments could help doctors avoid delays in cancer treatment.Interpretation · Explore ↗

Checked 2026-11-14 · Review due 2026-11-21

Read supporting source ↗
For many patients, heart screening…
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Skribe Medical · Financing Record

Explore source-linked visual explanations for Skribe Medical. Unsupported claims are withheld while source review continues.

Record 16031 · Recorded date: 2026-11-12

What it does

Skribe Medical, image from skribemedical.com

Skribe’s Resonant Body Power system enables a battery-free sensor design for maximum comfort – without sacrificing clinical accuracy.

Source: skribemedical.com ↗

Open record 16031 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime